The UK’s FTSE 100 experienced a decline on Monday, driven by a decrease in AstraZeneca shares following reports of a possible collaboration with U.S. drugmaker Bristol Myers Squibb. Additionally, lower oil prices negatively impacted energy giants BP and Shell. The blue-chip FTSE 100 index fell 0.10% to 10,857.49 points by 0931, while the mid-cap FTSE Read More
AstraZeneca
London’s FTSE 100 experienced an uptick on Monday, driven by a cessation in U.S.-Iran hostilities over the weekend, which led to a decrease in oil prices and enhanced global risk sentiment. However, a downturn in energy stocks limited the overall gains. The blue-chip FTSE 100 index rose 0.4% to 10,781 points by 0922, while the Read More
The UK’s FTSE 100 experienced a decline on Thursday as investors contended with escalating tensions in the Middle East. This downward movement was exacerbated by AstraZeneca, which reported unsatisfactory results from a late-stage trial, contributing to the overall market pressure. The blue-chip FTSE 100 index fell 0.6% to 10,417.63 points by 1045, while the midcap Read More
The UK stock market’s benchmark index FTSE 100 saw an upward movement following a flat start on Thursday morning, driven by advancements in the pharmaceuticals and consumer sectors. Easing concerns about inflation and interest rates contributed to the positive mood in the market. Investors are on the edge of their seats as they anticipate the Read More
Despite persistent worries over Middle East tensions and rumours that Hezbollah has rejected a fresh ceasefire deal with Israel, the benchmark index for the UK market, the FTSE 100, saw a slight increase in positive territory on Friday morning. Reports indicate that the Israel Defence Forces have eliminated Hezbollah’s engineering unit commander Abed Harb, thereby Read More
The UK stock market’s benchmark index experienced a decline on Friday, primarily driven by losses in the financial and mining sectors. Concerns regarding the ramifications of the persistent conflict in the Middle East also influenced sentiment. The FTSE 100 experienced a decline, falling to 10,293.03, reflecting a decrease of 59.89 points or 0.59% from its Read More
UK shares experienced a decline on Wednesday as traders processed a variety of earnings reports, subsequently shifting their focus to the policy decisions of global central banks, notably the Bank of England. The blue-chip FTSE 100 index dipped 0.7% by 0950, marking a decline for the seventh time in eight sessions. The midcap FTSE 250 Read More
On Monday, the primary stock indexes in the UK experienced a decline, reflecting a widespread downturn as concerns regarding the potential collapse of the U.S.-Iran ceasefire adversely impacted market sentiment. The United States has taken control of an Iranian cargo vessel, resulting in a significant disruption of traffic through the Strait of Hormuz, which has Read More
On Thursday, London’s blue-chip index experienced an uptick, driven primarily by financial and commodity stocks, as investors analyzed a varied set of corporate earnings reports. The FTSE 100 rose 0.5% by 1129, following a decline of 0.5% in the previous session. Meanwhile, the domestically focused FTSE 250 edged 0.1% lower. Investment banks and brokerages were Read More
The UK’s blue-chip index experienced a decline on Wednesday, influenced by losses in the banking and healthcare sectors, as investors analyzed corporate earnings while anticipating the policy decision from the U.S. Federal Reserve. The FTSE 100 fell 0.4% by 1056, while the domestically focused FTSE 250 bucked the trend, rising 0.1% and reaching its highest Read More








